Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$2.7B
Avg Funding
$108.5M
Cities
20

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Englewood Cliffs, United States
$11.7M
raised

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$25.5M
raised

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$600.0M
raised

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Markham, Canada
$5.0M
raised

1CM vision is to be the leading cannabis company globally with solutions that add value to consumers and companies.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$345.0M
raised

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$66.0M
raised

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Gothenburg, Sweden
$1.6M
raised

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$50.0M
raised

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Henderson, United States
$4.6M
raised

VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Marlborough, United States
$43.5M
raised

Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bromma, Sweden
$1.6M
raised

OncoZenge develops better products for the supportive care of cancer patients.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Burlington, Canada
$374K
raised

PROMINO is a nutraceutical company specializing in the development of patented and science-based products.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Naples, United States
$1.0M
raised

HealthLynked focuses on improving healthcare services.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Uppsala, Sweden
$22.4M
raised

Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Newark, United States
$24.9M
raised

Rafael Holdings is a company focused on the development of novel cancer therapies.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$795K
raised

Principal Technologies is a Canadian business that invests in healthcare technologies.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$150.0M
raised

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wilmington, United States
$1.9M
raised

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wilmington, United States
$22.3M
raised

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Uppsala, Sweden
$16.4M
raised

OssDsign is a medical-technology company developing implants for bone replacement.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sydney, Australia
$10.5M
raised

BCAL Diagnostics is a biotechnology company that focuses on the detection of women’s health issues.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$50.0M
raised

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$8.5M
raised

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$1.3B
raised

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Jun 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

434 Health Care Post-IPO Equity Startups (September 2026) — Page 4 | VCBacked